2002

Guidance for Industry on Labeling Over-the-Counter Human Drug Products--Updating Labeling in Reference Listed Drugs and Abbreviated New Drug Applications; Availability.    (18OCT02)
Click here for
txt or pdf
Prepublication display
The Guidance

Ingrown Toenail Relief Drug Products for Over-the-Counter Human Use.    (04OCT02)
Click here for
txt or pdf
Prepublication display

Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph, and Related Labeling.    (21AUG02)
Click here for
txt or pdf
Prepublication display

CDER 01185 Sunscreen Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment.    (20JUN02)
Click here for
txt or pdf
Prepublication display

Agency Information Collection Activities; Announcement of OMB Approval; Format and Content Requirements for Over-the-Counter (OTC) Drug Product Labeling.    (15MAY02)
Click here for
txt or pdf
Prepublication display
Supporting Statement

Pediculicide Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph.    (10MAY02)
Click here for
txt or pdf
Prepublication display

Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients addresses the ingredient octoxynol 9, considered in the rulemaking for OTC vaginal contraceptive drug products.   (09MAY02)
Click here for
txt or pdf
Prepublication display

Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients concerning stimulant laxative ingredients aloe (including aloe extract and aloe flower extract) and cascara sagrada (including casanthranol, cascara fluidextract aromatic, cascara sagrada bark, cascara sagrada extract, and cascara sagrada fluidextract).  (09MAY02)
Click here for
txt or pdf
Prepublication display

Over-the-Counter Human Drugs; Labeling Requirements; Partial Delay of Compliance Dates.    (05APR02)
Click here for
txt or pdf
Prepublication display

Anticaries Drug Products for Over-the-Counter Human Use; Use of Intraoral Appliance Models for Compliance with Biological Testing Requirements; Request for Information and Comments; Reopening of Comment Period.    (15MAR02)
Click here for
txt or pdf
Prepublication display

Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph ; Correction.  (15MAR02)
Click here for
txt or pdf
Prepublication display

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Format and Content Requirements for Over-the-Counter (OTC) Drug Product Labeling.    (26FEB02)
Click here for
txt or pdf
Prepublication display

Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph.    (08FEB02)
Click here for
txt or pdf
Prepublication display

Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded.   (23JAN02)
Click here for
txt or pdf
Prepublication display